Iraqi hotel accommodating U.S. workers hit by rocket bombs

Iraqi hotel accommodating U.S. workers hit by rocket bombs

BAGHDAD, Iraq - A Baghdad hotel where U.S. construction company employees are staying is checked Jan. 9 after being hit by rocket bombs. Iraqi police said no casualties were reported in the attack. (Kyodo)

  • Product Code
  • ILEA000022827
  • Registered date
  • 2004/1/09 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1228 × 1674 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 336.47(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    [Breaking News]Dollar drops below 140 yen line

    TOKYO, Japan, April 22 Kyodo - A monitor at a currency trading company in Tokyo shows on April 22, 2025, the U.S. dollar sinking below 140 yen for the first time since September 2024. (Kyodo)
      Nokia headquarters

      Nokia headquarters

      Nokia headquarters in Espoo, Finland, on October 19, 2023. Finnish network company Nokia released the third quarter result today. Nokia plans to reduce up to 14 000 workers before the end of the year 2026. LEHTIKUVA / JUSSI NUKARI - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Jussi Nukari/Lehtikuva/Kyodo News Images)
        Nokia headquarters

        Nokia headquarters

        Nokia headquarters in Espoo, Finland, on October 19, 2023. Finnish network company Nokia released the third quarter result today. Nokia plans to reduce up to 14 000 workers before the end of the year 2026. LEHTIKUVA / JUSSI NUKARI - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Jussi Nukari/Lehtikuva/Kyodo News Images)
          Nokia headquarters

          Nokia headquarters

          Nokia headquarters in Espoo, Finland, on October 19, 2023. Finnish network company Nokia released the third quarter result today. Nokia plans to reduce up to 14 000 workers before the end of the year 2026. LEHTIKUVA / JUSSI NUKARI - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Jussi Nukari/Lehtikuva/Kyodo News Images)
            Nokia headquarters

            Nokia headquarters

            Nokia headquarters in Espoo, Finland, on October 19, 2023. Finnish network company Nokia released the third quarter result today. Nokia plans to reduce up to 14 000 workers before the end of the year 2026. LEHTIKUVA / JUSSI NUKARI - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Jussi Nukari/Lehtikuva/Kyodo News Images)
              Nokia headquarters

              Nokia headquarters

              Nokia headquarters in Espoo, Finland, on October 19, 2023. Finnish network company Nokia released the third quarter result today. Nokia plans to reduce up to 14 000 workers before the end of the year 2026. LEHTIKUVA / JUSSI NUKARI - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Jussi Nukari/Lehtikuva/Kyodo News Images)
                Nokia headquarters

                Nokia headquarters

                Nokia headquarters in Espoo, Finland, on October 19, 2023. Finnish network company Nokia released the third quarter result today. Nokia plans to reduce up to 14 000 workers before the end of the year 2026. LEHTIKUVA / JUSSI NUKARI - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Jussi Nukari/Lehtikuva/Kyodo News Images)
                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                  Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                    Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.
                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      U.S. regulators OK Alzheimer's drug developed by Japan's Eisai

                      Japanese pharmaceutical maker Eisai Co. CEO Haruo Naito holds a press conference in Tokyo on Jan. 7, 2023, a day after the U.S. Food and Drug Administration approved lecanemab, an Alzheimer's drug developed by his company and U.S. firm Biogen Inc. for treatment in the early stage of the fatal, brain-robbing disease.